Literature DB >> 2773317

Inhibition of proteolytic activation of influenza virus hemagglutinin by specific peptidyl chloroalkyl ketones.

W Garten1, A Stieneke, E Shaw, P Wikstrom, H D Klenk.   

Abstract

Lysates of cultured cells have been analyzed for arginine-specific endoproteases using peptidyl-p-nitroanilides as chromogenic substrates. The enzymes present in MDBK, MDCK, VERO, BHK, and chick embryo cells required lysine-arginine or arginine-arginine pairs as cleavage sites, whereas chorioallantoic membrane cells contained, in addition, an activity that could cleave at a single arginine. The effect of peptidyl chloroalkyl ketones on the activation of the fowl plague virus hemagglutinin by the proteases specific for paired basic residues has been investigated. When virions containing uncleaved hemagglutinin were incubated with lysates of uninfected cells, cleavage was completely inhibited by peptidyl chloroalkyl ketones containing paired basic residues at a concentration of 1 mM. In contrast a compound containing a single arginine had no inhibitory activity. When dibasic peptidyl chloroalkyl ketones were added to infected cell cultures, cleavage of hemagglutinin and multiple cycles of virus replication were inhibited at 10 mM. However, a 100- to 200-fold increase of the inhibitory activity in intact cells could be achieved by N-terminal acylation. These studies suggest a potential role of peptidyl chloroalkyl ketones as antiviral agents.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2773317      PMCID: PMC7173068          DOI: 10.1016/0042-6822(89)90103-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  30 in total

1.  Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2).

Authors:  M Ohuchi; M Orlich; R Ohuchi; B E Simpson; W Garten; H D Klenk; R Rott
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Nucleotide sequence of Moloney murine leukaemia virus.

Authors:  T M Shinnick; R A Lerner; J G Sutcliffe
Journal:  Nature       Date:  1981 Oct 15-21       Impact factor: 49.962

4.  Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases.

Authors:  H W Davidson; C J Rhodes; J C Hutton
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

Review 5.  Biosynthesis of polyprotein precursors to regulatory peptides.

Authors:  E Herbert; M Uhler
Journal:  Cell       Date:  1982-08       Impact factor: 41.582

6.  Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage.

Authors:  W Garten; F X Bosch; D Linder; R Rott; H D Klenk
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

7.  Role of Staphylococcus protease in the development of influenza pneumonia.

Authors:  M Tashiro; P Ciborowski; H D Klenk; G Pulverer; R Rott
Journal:  Nature       Date:  1987 Feb 5-11       Impact factor: 49.962

8.  The properties of peptidyl diazoethanes and chloroethanes as protease inactivators.

Authors:  P Wikstrom; H Kirschke; S Stone; E Shaw
Journal:  Arch Biochem Biophys       Date:  1989-04       Impact factor: 4.013

9.  Yeast KEX2 endopeptidase correctly cleaves a neuroendocrine prohormone in mammalian cells.

Authors:  G Thomas; B A Thorne; L Thomas; R G Allen; D E Hruby; R Fuller; J Thorner
Journal:  Science       Date:  1988-07-08       Impact factor: 47.728

10.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

Authors:  J M McCune; L B Rabin; M B Feinberg; M Lieberman; J C Kosek; G R Reyes; I L Weissman
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

View more
  23 in total

1.  Furin is involved in baculovirus envelope fusion protein activation.

Authors:  Marcel Westenberg; Hualin Wang; Wilfred F J IJkel; Rob W Goldbach; Just M Vlak; Douwe Zuidema
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.

Authors:  Gero L Becker; Yinghui Lu; Kornelia Hardes; Boris Strehlow; Christine Levesque; Iris Lindberg; Kirsten Sandvig; Udo Bakowsky; Robert Day; Wolfgang Garten; Torsten Steinmetzer
Journal:  J Biol Chem       Date:  2012-04-26       Impact factor: 5.157

3.  Processing of the Borna disease virus glycoprotein gp94 by the subtilisin-like endoprotease furin.

Authors:  J A Richt; T Fürbringer; A Koch; I Pfeuffer; C Herden; I Bause-Niedrig; W Garten
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Proteolytic processing of the Cryptosporidium glycoprotein gp40/15 by human furin and by a parasite-derived furin-like protease activity.

Authors:  Jane W Wanyiri; Roberta O'Connor; Geneve Allison; Kami Kim; Anne Kane; Jiazhou Qiu; Andrew G Plaut; Honorine D Ward
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

5.  Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors.

Authors:  Eva Böttcher-Friebertshäuser; Catharina Freuer; Frank Sielaff; Sarah Schmidt; Markus Eickmann; Jennifer Uhlendorff; Torsten Steinmetzer; Hans-Dieter Klenk; Wolfgang Garten
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

6.  Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases.

Authors:  Oleg P Zhirnov; Mine R Ikizler; Peter F Wright
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus.

Authors:  A Kopp; E Blewett; V Misra; T C Mettenleiter
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  The synthesis of inhibitors for processing proteinases and their action on the Kex2 proteinase of yeast.

Authors:  H Angliker; P Wikstrom; E Shaw; C Brenner; R S Fuller
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

9.  Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.

Authors:  Bouchaib Bahbouhi; Nathalie Chazal; Nabil Georges Seidah; Cristina Chiva; Marcelo Kogan; Fernando Albericio; Ernest Giralt; Elmostafa Bahraoui
Journal:  Biochem J       Date:  2002-09-15       Impact factor: 3.857

10.  Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage.

Authors:  J Y Dong; J W Dubay; L G Perez; E Hunter
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.